Gallegos A - Search Results

1

Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival.

Raffel J, Bhattacharyya AK, Gallegos A, Cui H, Einspahr JG, Alberts DS, Powis G. Raffel J, et al. Among authors: gallegos a. J Lab Clin Med. 2003 Jul;142(1):46-51. doi: 10.1016/S0022-2143(03)00068-4. J Lab Clin Med. 2003. PMID: 12878985

2

Nuclear factor kappaB transactivation is increased but is not involved in the proliferative effects of thioredoxin overexpression in MCF-7 breast cancer cells.

Freemerman AJ, Gallegos A, Powis G. Freemerman AJ, et al. Among authors: gallegos a. Cancer Res. 1999 Aug 15;59(16):4090-4. Cancer Res. 1999. PMID: 10463612

3

Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.

Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G. Baker AF, et al. Among authors: gallegos a. Pancreas. 2008 Mar;36(2):178-86. doi: 10.1097/MPA.0b013e31815929fe. Pancreas. 2008. PMID: 18376310

4

Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.

Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, Powis G. Gallegos A, et al. Cancer Res. 1996 Dec 15;56(24):5765-70. Cancer Res. 1996. PMID: 8971189

5

Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.

Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G. Berggren M, et al. Among authors: gallegos a. Anticancer Res. 1996 Nov-Dec;16(6B):3459-66. Anticancer Res. 1996. PMID: 9042207

6

Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.

Gallegos A, Berggren M, Gasdaska JR, Powis G. Gallegos A, et al. Cancer Res. 1997 Nov 1;57(21):4965-70. Cancer Res. 1997. PMID: 9354464

7

Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival.

Grogan TM, Fenoglio-Prieser C, Zeheb R, Bellamy W, Frutiger Y, Vela E, Stemmerman G, Macdonald J, Richter L, Gallegos A, Powis G. Grogan TM, et al. Among authors: gallegos a. Hum Pathol. 2000 Apr;31(4):475-81. doi: 10.1053/hp.2000.6546. Hum Pathol. 2000. PMID: 10821495

8

Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin.

Berggren MI, Husbeck B, Samulitis B, Baker AF, Gallegos A, Powis G. Berggren MI, et al. Among authors: gallegos a. Arch Biochem Biophys. 2001 Aug 1;392(1):103-9. doi: 10.1006/abbi.2001.2435. Arch Biochem Biophys. 2001. PMID: 11469800

9

Cellular thioredoxin reductase activity is regulated by selenium.

Berggren M, Gallegos A, Gasdaska J, Powis G. Berggren M, et al. Among authors: gallegos a. Anticancer Res. 1997 Sep-Oct;17(5A):3377-80. Anticancer Res. 1997. PMID: 9413175

10

Down regulation of the expression of the p110, p85 and p55 subunits of phosphatidylinositol 3-kinase during colon cancer cell anchorage-independent growth.

Yeates LC, Gallegos A, Kozikowski AP, Powis G. Yeates LC, et al. Among authors: gallegos a. Anticancer Res. 1999 Sep-Oct;19(5B):4171-6. Anticancer Res. 1999. PMID: 10628371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters